BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2848200)

  • 1. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
    Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
    Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Wilms tumor.
    Ruteshouser EC; Huff V
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
    Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton MR; Narod SA
    Nat Genet; 1996 Aug; 13(4):461-3. PubMed ID: 8696342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for genetic heterogeneity in familial Wilms' tumor.
    Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
    Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus.
    Boehm T; Lavenir I; Forster A; Wadey RB; Cowell JK; Harbott J; Lampert F; Waters J; Sherrington P; Couillin P
    Oncogene; 1988 Dec; 3(6):691-5. PubMed ID: 2577871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
    Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
    Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
    McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
    Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
    Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
    Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
    Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
    Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
    Finver SN; Martiniere C; Kagan J; Cavenee W; Croce CM
    Oncogene Res; 1989; 5(2):143-8. PubMed ID: 2558334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial predisposition to Wilms tumor does not segregate with the WT1 gene.
    Schwartz CE; Haber DA; Stanton VP; Strong LC; Skolnick MH; Housman DE
    Genomics; 1991 Aug; 10(4):927-30. PubMed ID: 1655633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.